Financials
- Market Capitalization 218.17 M
- Employee 36
- Founded 2009
- CEO N/A
- Website www.corbuspharma.com
- Headquarter Delaware, United States
- FIGI BBG0078PJKQ7
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-1.54
ratio cours/chiffre d'affaires
29.09
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 3541 | GLSI Greenwich LifeSciences, Inc. - Common stock | 15.01 USD | +0.40% | -19.30% | +11.19% | +29.40% | 220.32 M USD | ||
| 3546 | KROS Keros Therapeutics, Inc. - common stock | 11.07 USD | -0.09% | -5.06% | +8.96% | -26.69% | 219.49 M USD | ||
| 3558 | PEPG PepGen Inc. - Common Stock | 3.12 USD | +4.35% | -8.50% | +76.27% | +164.41% | 216.09 M USD | ||
| 3565 | NERV Minerva Neurosciences, Inc - Common Stock | 4.48 USD | -1.75% | -10.58% | +13.42% | +88.24% | 213.91 M USD |